期刊
ACTA BIOMATERIALIA
卷 150, 期 -, 页码 413-426出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2022.07.015
关键词
Hypoxia; MSC-sEVs; Vascularized bone regeneration; Angiogenesis; miR-210-3p
资金
- National Natural Science Foundation [82072396, 81571022]
- Program of Shanghai Academic/Technology Research Leader [19XD1434500]
- Double Hundred Plan [20191819]
- Interdisciplinary Program of Shanghai Jiao Tong University [YG2021ZD12]
- Three Year Action Plan to Promote Clinical Skills and Clinical Creativity in Municipal Hospitals [YG2017MS06]
- Research Fund of Medicine and Engineering of Shanghai Jiao Tong University [JYLJ023]
- Clinical Research Program of Ninth Peoples Hospital, Shanghai Jiao Tong University School of Medicine [DLY201808]
- Multicenter clinical research project of Shanghai Jiao Tong University School of Medicine [2019-I2M-5-037]
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- [16CR10308B]
Angiogenesis is crucial for ideal bone regeneration, and promoting angiogenesis during bone repair is vital. Hypoxia-preconditioned small extracellular vesicles (hypo-sEVs) derived from mesenchymal stem cells (MSCs) enhance angiogenesis through the miR-210-3p/EFNA3/PI3K/AKT pathway, providing an effective strategy for vascularized bone regeneration.
Angiogenesis is closely coupled with osteogenesis and has equal importance. Thus, promoting angiogenesis during the bone repair process is vital for ideal bone regeneration. As important mediators of cell-cell communication and biological homeostasis, mesenchymal stem cell-derived small extracellular vesicles (MSC-sEVs) have been proved to be highly involved in bone and vascular regeneration. Because hypoxia microenvironment promotes the proangiogenic activity of MSCs, in the present study, we investigate the effect and underlying molecular mechanisms of sEVs from hypoxia-preconditioned MSCs (hypo-sEVs) on angiogenesis and develop an effective strategy to promote vascularized bone regeneration. Compared to sEVs from normoxia MSCs (nor-sEVs), hypo-sEVs promoted the proliferation, migration, and angiogenesis of HUVECs and ultimately enhanced bone regeneration and new blood vessel reconstruction in a critical-size calvarial bone defect model. miRNA sequence and the verified results showed that miR-210-3p in hypo-sEVs was increased via HIF-1 alpha under hypoxia. The upregulated miR-210-3p in hypo-sEVs promoted angiogenesis by downregulating EFNA3 expression and enhancing the phosphorylation of the PI3K/AKT pathway. Thus, this study suggests a successful strategy to enhance vascularized bone regeneration by utilizing hypo-sEVs via the miR-210-3p/EFNA3/PI3K/AKT pathway. Statement of significance Considering the significance of vascularization in ideal bone regeneration, strategies to promote angiogenesis during bone repair are required. Hypoxia microenvironment can promote the proangiogenic potential of mesenchymal stem cells (MSCs). Nonetheless, the therapeutic effect of small extracellular vesicles (sEVs) from hypoxia-preconditioned MSCs on cranio-maxillofacial bone defect remains unknown, and the underlying mechanism is poorly understood. This study shows that hypo-sEVs significantly enhance the proliferation, migration, and angiogenesis of HUVECs as well as promote vascularized bone formation. Moreover, this work indicates that HIF-1 alpha can induce overexpression of miR-210-3p under hypoxia, and miR-210-3p can hinder EFNA3 expression and subsequently activate the PI3K/AKT pathway. The application of hypo-sEVs provides a facile and promising strategy to promote vascularized bone regeneration in a critical-size bone defect model. (c) 2022 The Authors. Published by Elsevier Ltd on behalf of Acta Materialia Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据